Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
FTC Wants Shkreli Sanctioned Over Pharma Industry Ban
The Federal Trade Commission and seven states asked a New York federal judge Tuesday to hold Martin Shkreli in contempt for violating a court order banning him from the pharmaceutical industry... To view the full article, register now. Already a…
Pharma Bro Martin Shkreli Could Be in Big Trouble Again
The Federal Trade Commission has asked a federal judge to hold Martin Shkreli, the former pharmaceutical executive better known as “Pharma Bro” in the 2010s, in contempt of court for allegedly publicly trading in pharmaceutical…
Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion
Zealand Pharma A/S is teaming up with Generate Biomedicines Inc. in a billion-dollar deal to develop new obesity treatments using artificial intelligence, expanding the race for the next generation of weight-loss drugs. The Danish biotechnology…
Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
Martin Shkreli—the ex-pharmaceutical executive infamous for illegally hiking the price of a lifesaving anti-parasitic drug by more than 4,000 percent and getting a seven-year prison sentence for the fraudulent scheme he used to do it—…
'Pharma Bro' Martin Shkreli broke lifetime ban on drug industry trades, feds say
“Pharma Bro” Martin Shkreli is blatantly violating his court-ordered lifetime ban from the pharmaceutical industry by trading stocks and boasting about his market bets on social media, the feds and local prosecutors say. The Federal…
Personalised cancer vaccines take a leap forward - can Swiss pharma catch up?
For decades, the idea of a vaccine to treat cancer promised more than it delivered. That may be changing. This summer, the first successful Phase III trial of an mRNA vaccine designed around each patient's own tumour was announcedExternal link by…
Forget Treasury Bonds: This 6%-Yielding Pharma Stock Pays You to Wait for Its Pipeline
Treasury bonds offer steady, risk-free income, but Pfizer (PFE +2.59%) brings something extra to the table: a roughly 6% dividend yield and the potential for a massive turnaround. The pharmaceutical giant is expanding its portfolio beyond its…
MEPs pause vote on EU pesticides bill, as UN experts join scientists in opposition to Big Pharma
A backlash is building against an EU ‘omnibus' bill that seeks to make it easier to authorise and use pesticides across the bloc. MEPs are still yet to set a date to vote on the European Commission's proposal to extend how long pesticide…
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
Big drugmakers lose blockbusters to biosimilars and generics all the time. The strongest income payers keep paying anyway, because the next wave of drugs is already throwing off cash. This roster of five US-listed pharma companies is built around…
Pharmalittle: We're reading about Sanofi settling an EU antitrust probe, 'pharma bro' Shkreli, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you…
Early gains fade by afternoon; Insurance, Pharma stocks pull indices lower
Equity benchmarks surrendered their opening gains and turned negative by midday on Wednesday, as selling in insurance and pharmaceutical stocks offset continued strength in information technology. At 1.05 pm, the Nifty 50 was trading at 22,615.25…
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 12-Month Low - Here's Why
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) reached a new 52-week low on Wednesday. The company traded as low as $20.04 and last traded at $20.19, with a volume of 989,284 shares traded. The stock had previously closed at…
Pharma company registered at a Falls Church Staples goes public, raises $45M
A Falls Church-based pharmaceutical company has raised $45 million since going public last week, surpassing its original goal. Retension Pharmaceuticals Inc., a 12-person company whose publicly listed address is a Staples store in Falls Church, hit…
NervGen Pharma (NASDAQ:NGEN) Stock Has Average Target Price of $14.00
NervGen Pharma (NASDAQ:NGEN - Get Free Report) has been assigned a consensus rating of 'Moderate Buy' from the six research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a…
Avalyn Pharma (NASDAQ:AVLN) Sets New 1-Year Low - Here's What Happened
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s stock price reached a new 52-week low during trading on Wednesday. The stock traded as low as $23.08 and last traded at $23.74, with a volume of 403,934 shares. The stock had previously closed at…
Receive a Daily briefing on Pharma Industry News
Get Started